Spotlights
In pre-clinical studies, researchers found that low-dose ketamine infusions can improve pain, depression and levodopa-induced dyskinesia in Parkinson's patients.
Give yourself the gift of good health! The University of Arizona Health Sciences is offering an uplifting program to improve health and reduce stress.
Researchers in the College of Pharmacy say compounds targeting proteins involved in viral replication may further drug development for treating COVID-19.
Dr. Donna D. Zhang’s research focuses on developing pharmaceuticals to prevent or treat exposure to arsenic, which has affected more than 160 million people worldwide.
The tele-ultrasound training program for lung point-of-care ultrasound (POCUS) will enable rural emergency departments to more effectively identify and treat suspected COVID-19 patients.
The Arizona portion of an 11-state effort, funded by a $12 million federal award, to address the uneven impact of the pandemic on racial and ethnic minority communities will be led by the UArizona Health Sciences.
The gift from breast cancer survivor and longtime UArizona supporter Ginny Clements establishes an endowment for the new institute, along with endowed positions and renovated lab space.
A microRNA that can be found in a blood sample may make it easier to detect gastric cancer and could lead to improved treatment for diseases that are resistant to common immunotherapies.
Researchers developed one of the most accurate COVID-19 antibody tests available and now have shown antibodies persist for months after infection, providing long-term immunity.
The $2.3 million National Institutes of Health grant will enable Dr. Alicia Allen to explore how women’s hormones influence postpartum opioid relapse and if they may be used as a preventative strategy.